Sarah Elkourashy Presents Insights on Caplacizumab for TTP at ASH25
Sarah Elkourashy, Consultant in Clinical Hematology and BMT at Hamad Medical Corporation, Assistant professor of clinical medicine at Weill Cornell Medicine-Qatar, shared on LinkedIn:
”Happy to be part of ASH Conference 2025 – ASH2025
It was a pleasure reconnecting with former colleagues and engaging with peers from across the hematology community.
The meeting offered valuable insights into the latest advances in hematology and meaningful discussions on how to further enhance the care of patients with hematological disorders.
Thankful for the rich scientific exchange and collaborative environment.
Delighted to present our poster there Shehab Mohamed, Abdulrahman Al-Mashdali
Abstracts accepted:
1.Real-world descriptive analysis of the use of bispecific t cell engagers (BiTEs) in the treatment of hematological malignancies in Qatar: A state-wide retrospective study cohort
Read the full article in Blood.
Authors: Rawan Dawoud, Farah Jibril, Maria Benkhadra, Sahar Nasser, Amaal Gulied, Anas Hamad, Honar Charif, Mohamed Yassin, Ruba Yasin Taha, Safaa Alazawi, Hesham Elsabah, Deena Mudawi, Sarah Elkourashy, Shereen Elazzazy
2.Caplacizumab as a pre-emptive therapy in thrombotic thrombocytopenic purpura: A proactive strategy to reduce morbidity
Read the full article in Blood.
Authors: Maria Benkhadra, Abdulrahman Al-Mashdali, Sarah Elkourashy, Anas Hamad, Shehab Mohamed, Halima El Omri, Honar Cherif
3.Caplacizumab for pediatric immune thrombotic thrombocytopenic purpura: A scoping review of current evidence
Read the full article in Blood.
Authors: Abdulrahman Al-Mashdali, Samah M Salihb, Priyadarshini Vatsyayanc, Deena Mudawi, Sarah Elkourashy, Dina Soliman, Honar Charif, Shehab Mohamed
All from ASH25 featured in Hemostasis Today.
-
May 10, 2026, 00:50Abdulla A. Damluji: Pulsed Field Ablation Delivers a New Standard for Persistent AF
-
May 10, 2026, 00:48Kirti Sharma: Immune Thrombocytopenia Market Set for Strong Growth Through 2036
-
May 10, 2026, 00:41Ram Chaganti: Could Immune Tolerance Be Engineered in Chronic Immune Thrombocytopenia?
-
May 9, 2026, 23:50Manuel Carbonell: Modern Phlebology Should Not Be a Competition of Devices and Technology
-
May 9, 2026, 23:37Maia Meier’s Journey: Raising Awareness for Women Living Without a Diagnosis – European Haemophilia Consortium
-
May 9, 2026, 23:13Aakanksha Angra: Building a Community for Advances in ALL
-
May 9, 2026, 22:55Romiplostim Versus Placebo in the Management of Chemotherapy-Induced Thrombocytopenia – Transfusion Evidence Library
-
May 9, 2026, 22:43Simon Ash: Gestational Thrombocytopenia and Maternal Risk at SOAPAM 2026
-
May 9, 2026, 22:18Rupam Manna: Thrombocytopenia in Oncology – Complete High-Yield Guide for Safe Chemotherapy Delivery